AI Verdict
IBRX has stronger fundamentals based on our AI analysis.
ICHR vs IBRX Fundamental Comparison
| Metric | ICHR | IBRX |
|---|---|---|
| Revenue | $947.7M | $113.3M |
| Net Income | $-52.8M | $-351.4M |
| Net Margin | -5.6% | -310.2% |
| ROE | -8.0% | N/A |
| ROA | -5.6% | -70.0% |
| Current Ratio | 3.16x | 5.10x |
| Debt/Equity | 0.19x | N/A |
| EPS | $-1.54 | $-0.38 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ICHR vs IBRX: Frequently Asked Questions
Is ICHR or IBRX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IBRX has stronger fundamentals. ICHR is rated STRONG SELL (78% confidence) while IBRX is rated STRONG SELL (92% confidence). This is not investment advice.
How does ICHR compare to IBRX fundamentally?
ICHOR HOLDINGS, LTD. has ROE of -8.0% vs ImmunityBio, Inc.'s N/A. Net margins are -5.6% vs -310.2% respectively.
Which stock pays higher dividends, ICHR or IBRX?
ICHR has a dividend yield of N/A or no dividend while IBRX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ICHR or IBRX for long term?
For long-term investing, consider that ICHR has STRONG SELL rating with 78% confidence, while IBRX has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ICHR vs IBRX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ICHR vs IBRX, the AI consensus favors IBRX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.